{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:01:03Z","timestamp":1768438863402,"version":"3.49.0"},"publisher-location":"Vienna","reference-count":169,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211735732","type":"print"},{"value":"9783211735749","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-3-211-73574-9_12","type":"book-chapter","created":{"date-parts":[[2007,12,27]],"date-time":"2007-12-27T18:43:42Z","timestamp":1198781022000},"page":"91-104","source":"Crossref","is-referenced-by-count":63,"title":["Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study"],"prefix":"10.1007","author":[{"given":"K. A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ana.20635","volume":"58","author":"D. Aarsland","year":"2005","unstructured":"Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005a) Neuropathology of dementia in Parkinson\u2019s disease: a prospective, community-based study. Ann Neurol 58: 773\u2013776","journal-title":"Ann Neurol"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/mds.20527","volume":"20","author":"D. Aarsland","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C (2005b) A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord 20: 1255\u20131263","journal-title":"Mov Disord"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/jnnp.2006.091322","volume":"77","author":"W.F. Abdo","year":"2006","unstructured":"Abdo WF, Borm GF, Munneke M, Verbeek MM, Esselink RA, Bloem BR (2006) Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 77: 1367\u20131369","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 15","key":"12_CR4","first-page":"538","volume":"21","author":"C.H. Adler","year":"2006","unstructured":"Adler CH, Grover AC, Sabbagh MN, Caviness JN, Connor DJ, Beach TG (2006) Clinical and pathologic findings in PD with LRRK2 mutations: 2 cases with mild cognitive impairment and small amplitude myoclonus. Mov Disord 21Suppl 15: S538","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"12_CR5","first-page":"96","volume":"12","author":"O. Ansorge","year":"1997","unstructured":"Ansorge O, Lees AJ, Daniel SE (1997) Update on the accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease. Mov Disord 12Suppl 1: 96","journal-title":"Mov Disord"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","volume":"59","author":"H. Apaydin","year":"2002","unstructured":"Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 59: 102\u2013112","journal-title":"Arch Neurol"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0006-8993(00)03082-1","volume":"888","author":"Y. Arai","year":"2001","unstructured":"Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y (2001) Alpha-synuclein-positive structures in cases with sporadic Alzheimer\u2019s disease: morphology and its relationship to tau aggregation. Brain Res 888: 287\u2013296","journal-title":"Brain Res"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00401-006-0146-9","volume":"113","author":"J. Attems","year":"2007","unstructured":"Attems J, Quass M, Jellinger KA (2007) Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol (Berl) 113: 53\u201362","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C. Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019s Brien J, McKeith I, Perry E, Aarsland D (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67: 1931\u20131934","journal-title":"Neurology"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-005-0447-5","volume":"113","author":"D. Berg","year":"2006","unstructured":"Berg D (2006a) In vivo detection of iron and neuromelanin by transcranial sonography \u2014 a new approach for early detection of substantia nigra damage. J Neural Transm 113: 775\u2013780","journal-title":"J Neural Transm"},{"key":"12_CR11","doi-asserted-by":"crossref","unstructured":"Berg D (2006b) Transcranial sonography in the early and differential diagnosis of Parkinson\u2019s disease. J Neural Transm Suppl: 249\u2013254","DOI":"10.1007\/978-3-211-45295-0_38"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A. Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32: 284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"N.I. Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS, Lopresti B, Koeppe RA, Davis JG, Mathis CA, Moore RY, DeKosky ST (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60: 1745\u20131748","journal-title":"Arch Neurol"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","volume":"26","author":"N.I. Bohnen","year":"2006","unstructured":"Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA (2006) Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 26: 1198\u20131212","journal-title":"J Cereb Blood Flow Metab"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","volume":"111","author":"J.L.W. Bosboom","year":"2004","unstructured":"Bosboom JLW, Stoffers D, Wolters EC (2004) Cognitive dysfunction and dementia in Parkinson\u2019s disease. J Neural Transm 111: 1303\u20131315","journal-title":"J Neural Transm"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/mds.10202","volume":"17","author":"J.H. Bower","year":"2002","unstructured":"Bower JH, Dickson DW, Taylor L, Maraganore DM, Rocca WA (2002) Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord 17: 910\u2013916","journal-title":"Mov Disord"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H. Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H. Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24: 197\u2013211","journal-title":"Neurobiol Aging"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H. Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318: 121\u2013134","journal-title":"Cell Tissue Res"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H. Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64: 1404\u20131410","journal-title":"Neurology"},{"key":"12_CR21","first-page":"89","volume":"70","author":"H. Braak","year":"2006","unstructured":"Braak H, M\u00fcller CM, R\u00fcb U, Ackermann H, Bratzke H, de Vos RAI, Del Tredici K (2006) Pathology associated with sporadic Parkinson\u2019s disease \u2014 Where does it end? J Neural Transm Suppl 70: 89\u201397","journal-title":"J Neural Transm Suppl"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.biopsych.2005.12.017","volume":"59","author":"D.J. Brooks","year":"2006","unstructured":"Brooks DJ, Piccini P (2006) Imaging in Parkinson\u2019s disease: the role of monoamines in behavior. Biol Psychiatry 59: 908\u2013918","journal-title":"Biol Psychiatry"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005072-199801000-00006","volume":"57","author":"D.F. Brown","year":"1998","unstructured":"Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CLr (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57: 39\u201346","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/brain\/awh088","volume":"127","author":"E.J. Burton","year":"2004","unstructured":"Burton EJ, McKeith IG, Burn DJ, Williams ED, O\u2019Brien JT (2004) Cerebral atrophy in Parkinson\u2019s disease with and without dementia: a comparison with Alzheimer\u2019s disease, dementia with Lewy bodies and controls. Brain 127: 791\u2013800","journal-title":"Brain"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mds.20652","volume":"20","author":"E.J. Burton","year":"2005","unstructured":"Burton EJ, McKeith IG, Burn DJ, O\u2019 Brien JT (2005) Brain atrophy rates in Parkinson\u2019 disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20: 1571\u20131576","journal-title":"Mov Disord"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R. Camicioli","year":"2003","unstructured":"Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord 18: 784\u2013790","journal-title":"Mov Disord"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.parkreldis.2004.04.002","volume":"10","author":"K.L. Chou","year":"2004","unstructured":"Chou KL, Hurtig HI, Stern MB, Colcher A, Ravina B, Newberg A, Mozley PD, Siderowf A (2004) Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson\u2019s disease. Parkinsonism Relat Disord 10: 375\u2013379","journal-title":"Parkinsonism Relat Disord"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C. Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74: 852\u2013856","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR29","first-page":"218","volume-title":"Scientific basis for the treatment of Parkinson\u2019s disease","author":"A. Dagher","year":"2005","unstructured":"Dagher A (2005) Functional imaging in Parkinson\u2019s disease. In: G\u00e1lvez-Jimenez N (ed) Scientific basis for the treatment of Parkinson\u2019s disease, 2nd edn. Taylor & Francis, New York, pp 218\u2013231","edition":"2nd edn."},{"key":"12_CR30","first-page":"165","volume":"39","author":"S.E. Daniel","year":"1993","unstructured":"Daniel SE, Lees AJ (1993) Parkinson\u2019s Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39: 165\u2013172","journal-title":"J Neural Transm Suppl"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archneur.62.8.1265","volume":"62","author":"L.M. Lau de","year":"2005","unstructured":"de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 62: 1265\u20131269","journal-title":"Arch Neurol"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/B978-012088592-3\/50077-3","volume-title":"Neurobiology of disease","author":"V. Dhawan","year":"2007","unstructured":"Dhawan V, Eidelberg D (2007) PET imaging in Parkinson\u2019s disease and other neurodegenerative disorders. In: Gilman S (ed) Neurobiology of disease. Elsevier Academic Press, Amsterdam, pp 821\u2013828"},{"issue":"Suppl 2","key":"12_CR33","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"D.W. Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246Suppl 2: II6\u2013II15","journal-title":"J Neurol"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","volume":"61","author":"D.W. Dickson","year":"2002","unstructured":"Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61: 935\u2013946","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 15","key":"12_CR35","first-page":"559","volume":"21","author":"D.W. Dickson","year":"2006","unstructured":"Dickson DW, Uchikado H, Klos KJ, Josephs KA, Boeve BF, Ahlskog J (2006) A critical review of the Braak staging scheme for Parkinson\u2019s disease. Mov Disord 21Suppl 15: S-559","journal-title":"Mov Disord"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00401-005-0015-y","volume":"111","author":"Z.T. Ding","year":"2006","unstructured":"Ding ZT, Wang Y, Jiang YP, Hashizume Y, Yoshida M, Mimuro M, Inagaki T, Iwase T (2006) Characteristics of alpha-synucleinopathy in centenarians. Acta Neuropathol (Berl) 111: 450\u2013458","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jnnp.55.2.138","volume":"55","author":"R.L. Doty","year":"1992","unstructured":"Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 55: 138\u2013142","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1096\/fj.06-6092com","volume":"20","author":"T. Duka","year":"2006","unstructured":"Duka T, Rusnak M, Drolet RE, Duka V, Wersinger C, Goudreau JL, Sidhu A (2006) Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism. Faseb J 20: 2302\u20132312","journal-title":"Faseb J"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","volume":"26","author":"T. Eckert","year":"2005","unstructured":"Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26: 912\u2013921","journal-title":"Neuroimage"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","volume":"76","author":"J. Eerola","year":"2005","unstructured":"Eerola J, Tienari PJ, Kaakkola S, Nikkinen P, Launes J (2005) How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry 76: 1211\u20131216","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"O.M. El-Agnaf","year":"2003","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MI, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. Faseb J 17: 1945\u20131947","journal-title":"Faseb J"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"O.M. El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. Faseb J 20: 419\u2013425","journal-title":"Faseb J"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","volume":"2","author":"M. Emre","year":"2003","unstructured":"Emre M (2003) Dementia associated with Parkinson\u2019s disease. Lancet Neurol 2: 229\u2013237","journal-title":"Lancet Neurol"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/PL00007856","volume":"249","author":"T. Foltynie","year":"2002","unstructured":"Foltynie T, Brayne C, Barker RA (2002) The heterogeneity of idiopathic Parkinson\u2019s disease. J Neurol 249: 138\u2013145","journal-title":"J Neurol"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.20688","volume":"59","author":"M. Fujita","year":"2006","unstructured":"Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB (2006) Widespread decrease of nicotinic acetylcholine receptors in Parkinson\u2019s disease. Ann Neurol 59: 174\u2013177","journal-title":"Ann Neurol"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S1474-4422(06)70578-6","volume":"5","author":"H.C. Fung","year":"2006","unstructured":"Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A (2006) Genome-wide genotyping in Parkinson\u2019s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5: 911\u2013916","journal-title":"Lancet Neurol"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.20819","volume":"59","author":"W.R. Galpern","year":"2006","unstructured":"Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59: 449\u2013458","journal-title":"Ann Neurol"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","volume":"67","author":"J.E. Galvin","year":"2006","unstructured":"Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67: 1605\u20131611","journal-title":"Neurology"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.expneurol.2004.12.002","volume":"192","author":"J.W. Geddes","year":"2005","unstructured":"Geddes JW (2005) Alpha-synuclein: a potent inducer of tau pathology. Exp Neurol 192: 244\u2013250","journal-title":"Exp Neurol"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"D.J. Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56: 33\u201339","journal-title":"Arch Neurol"},{"issue":"Suppl 12","key":"12_CR51","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1002\/mds.20535","volume":"20","author":"F. Geser","year":"2005","unstructured":"Geser F, Wenning GK, Poewe W, McKeith I (2005) How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 20Suppl 12: S11\u2013S20","journal-title":"Mov Disord"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"B.I. Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300: 636\u2013640","journal-title":"Science"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"B.I. Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM (2006) Biochemical and pathological characterization of Lrrk2. Ann Neurol 59: 315\u2013322","journal-title":"Ann Neurol"},{"key":"12_CR54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"W.R. Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51: 745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","volume":"163","author":"S. Gilman","year":"1999","unstructured":"Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163: 94\u201398","journal-title":"J Neurol Sci"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s004010051135","volume":"99","author":"E. Gomez-Tortosa","year":"2000","unstructured":"Gomez-Tortosa E, Newell K, Irizarry MC, Sanders JL, Hyman BT (2000) Alpha-synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol (Berl) 99: 352\u2013357","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR57","doi-asserted-by":"crossref","unstructured":"Halliday GM, Del Tredici K, Braak H (2006) Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson\u2019s disease. J Neural Transm Suppl: 99\u2013103","DOI":"10.1007\/978-3-211-45295-0_16"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"R.L. Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10: 378\u2013384","journal-title":"Brain Pathol"},{"key":"12_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L. Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M et al. (1990) The Lewy body variant of Alzheimer\u2019s disease: a clinical and pathologic entity. Neurology 40: 1\u20138","journal-title":"Neurology"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000095641","volume":"22","author":"H. Hanyu","year":"2006","unstructured":"Hanyu H, Shimizu S, Hirao K, Sakurai H, Iwamoto T, Chikamori T, Hida S, Yamashina A, Koizumi K, Abe K (2006) The role of 1231-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dement Geriatr Cogn Disord 22: 379\u2013384","journal-title":"Dement Geriatr Cogn Disord"},{"key":"12_CR61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"A.J. Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (Berl) 102: 355\u2013363","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.21022","volume":"60","author":"J. Hardy","year":"2006","unstructured":"Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson\u2019s disease and parkinsonism. Ann Neurol 60: 389\u2013398","journal-title":"Ann Neurol"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0404.2005.00389.x","volume":"112","author":"K. Haugarvoll","year":"2005","unstructured":"Haugarvoll K, Aarsland D, Wentzel-Larsen T, Larsen JP (2005) The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson\u2019s disease. Acta Neurol Scand 112: 386\u2013390","journal-title":"Acta Neurol Scand"},{"key":"12_CR64","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","volume":"44","author":"J.J. Hauw","year":"1994","unstructured":"Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015\u20132019","journal-title":"Neurology"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","volume":"65","author":"R. Hilker","year":"2005","unstructured":"Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD (2005) Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65: 1716\u20131722","journal-title":"Neurology"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/mds.20216","volume":"19","author":"P. Hobson","year":"2004","unstructured":"Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson\u2019s disease in the United Kingdom. Mov Disord 19: 1043","journal-title":"Mov Disord"},{"key":"12_CR67","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"A.J. Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992a) What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study. Neurology 42: 1142\u20131146","journal-title":"Neurology"},{"key":"12_CR68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"A.J. Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992b) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR69","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","volume":"57","author":"A.J. Hughes","year":"2001","unstructured":"Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease. Neurology 57: 1497\u20131499","journal-title":"Neurology"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","volume":"125","author":"A.J. Hughes","year":"2002","unstructured":"Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125: 861\u2013870","journal-title":"Brain"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","volume":"110","author":"T.A. Hughes","year":"2004","unstructured":"Hughes TA, Ross HF, Mindham RH, Spokes EG (2004) Mortality in Parkinson\u2019s disease and its association with dementia and depression. Acta Neurol Scand 110: 118\u2013123","journal-title":"Acta Neurol Scand"},{"key":"12_CR72","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"H.I. Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 54: 1916\u20131921","journal-title":"Neurology"},{"key":"12_CR73","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"B.T. Hyman","year":"1997","unstructured":"Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095\u20131097","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2006.01.006","volume":"244","author":"J.H. Im","year":"2006","unstructured":"Im JH, Chung SJ, Kim JS, Lee MC (2006) Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson\u2019s disease: analysis with [(123)I]IPT single photon emission computed tomography. J Neurol Sci 244: 103\u2013109","journal-title":"J Neurol Sci"},{"key":"12_CR75","first-page":"188","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"P.G. Ince","year":"2003","unstructured":"Ince PG, McKeith IG (2003) Dementia with Lewy bodies. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Press, Basel, pp 188\u2013199"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3940(99)00178-0","volume":"265","author":"E. Iseki","year":"1999","unstructured":"Iseki E, Marui W, Kosaka K, Ueda K (1999) Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease. Neurosci Lett 265: 9\u201312","journal-title":"Neurosci Lett"},{"key":"12_CR77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-002-0644-3","volume":"105","author":"E. Iseki","year":"2003","unstructured":"Iseki E, Togo T, Suzuki K, Katsuse O, Marui W, de Silva R, Lees A, Yamamoto T, Kosaka K (2003) Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol (Berl) 105: 265\u2013270","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR78","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T. Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 62: 389\u2013397","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","volume":"63","author":"S. Jain","year":"2006","unstructured":"Jain S, Lo SE, Louis ED (2006) Common misdiagnosis of a common neurological disorder: How are we misdiagnosing essential tremor? Arch Neurol 63: 1100\u20131104","journal-title":"Arch Neurol"},{"key":"12_CR80","first-page":"124","volume-title":"Movement disorders","author":"K. Jellinger","year":"1987","unstructured":"Jellinger K (1987) The pathology of parkinsonism. In: Marsden C, Fahn S (eds) Movement disorders. Butterworth, London, pp 124\u2013165"},{"key":"12_CR81","first-page":"55","volume":"86","author":"K.A. Jellinger","year":"2001","unstructured":"Jellinger KA (2001) The pathology of Parkinson\u2019s disease. Adv Neurol 86: 55\u201372","journal-title":"Adv Neurol"},{"key":"12_CR82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"K.A. Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109: 329\u2013339","journal-title":"J Neural Transm"},{"key":"12_CR83","first-page":"159","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"K.A. Jellinger","year":"2003","unstructured":"Jellinger KA, Mizuno Y (2003) Parkinson disease. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 159\u2013185"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","volume":"106","author":"K.A. Jellinger","year":"2003","unstructured":"Jellinger KA (2003a) Alpha-synuclein pathology in Parkinson and Alzheimer disease brain: incidence and topographic distribution \u2014 a pilot study. Acta Neuropathol 106: 191\u2013201","journal-title":"Acta Neuropathol"},{"key":"12_CR85","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1385\/1-59259-326-7:231","volume-title":"Mental and behavioral dysfunction in movement disorder","author":"K.A. Jellinger","year":"2003","unstructured":"Jellinger KA (2003b) Neuropathological distinctions and similarities in movement disorders with dementia. In: B\u00e9dard MA, Agid Y, Chouinard S, Fahn S, Korczyn AD, Lesp\u00e9rance P (eds) Mental and behavioral dysfunction in movement disorder. Humana Press Inc., Totowa, NJ, pp 231\u2013254"},{"key":"12_CR86","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"K.A. Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body related alpha-synucleinopathy in the aged human brain. J Neural Transm 111: 1219\u20131235","journal-title":"J Neural Transm"},{"key":"12_CR87","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1600-0404.2004.00360.x","volume":"111","author":"K.A. Jellinger","year":"2005","unstructured":"Jellinger KA (2005) Mortality in Parkinson\u2019s disease. Acta Neurol Scand 111: 71; author reply 72","journal-title":"Acta Neurol Scand"},{"key":"12_CR88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"K.A. Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol (Berl) 112: 253\u2013260","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/9781420016819-12","volume-title":"Early diagnosis of dementias","author":"K.A. Jellinger","year":"2006","unstructured":"Jellinger KA (2006a) A view on early diagnosis of dementias from neuropathology. In: Herholz K, Morris C, Perani D (eds) Early diagnosis of dementias. Marcel Dekker, New York, pp 311\u2013428"},{"key":"12_CR90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2006-9S308","volume":"9","author":"K.A. Jellinger","year":"2006","unstructured":"Jellinger KA (2006b) Clinicopathological analysis of dementia \u2014 an update. J Alzheimers Dis 9: 61\u201370","journal-title":"J Alzheimers Dis"},{"key":"12_CR91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2006.05.002","volume":"248","author":"K.A. Jellinger","year":"2006","unstructured":"Jellinger KA (2006c) The morphological basis of mental dysfunction in Parkinson\u2019s disease. J Neurol Sci 248: 167\u2013172","journal-title":"J Neurol Sci"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/mds.20371","volume":"20","author":"C. Junque","year":"2005","unstructured":"Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Marti MJ, Pastor P, Gomez-Anson B, Mercader JM (2005) Amygdalar and hippocampal MRI volumetric reductions in Parkinson\u2019s disease with dementia. Mov Disord 20: 540\u2013544","journal-title":"Mov Disord"},{"key":"12_CR93","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/mds.10523","volume":"18","author":"R. Katzenschlager","year":"2003","unstructured":"Katzenschlager R, Cardozo A, Avila Cobo MR, Tolosa E, Lees AJ (2003) Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Mov Disord 18: 1123\u20131131","journal-title":"Mov Disord"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/mds.21112","volume":"21","author":"J.S. Kim","year":"2006","unstructured":"Kim JS, Lee PH, Lee KS, Park JW, Kim YI, Chung YA, Kim SH, Kim J, Choi YY, Kim HT (2006) Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism. Mov Disord 21: 1990\u20131994","journal-title":"Mov Disord"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncpneuro0126","volume":"2","author":"C. Klein","year":"2006","unstructured":"Klein C, Schlossmacher MG (2006) The genetics of Parkinson disease: implications for neurological care. Nat Clin Pract Neurol 2: 136\u2013146","journal-title":"Nat Clin Pract Neurol"},{"key":"12_CR96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0705-2","volume":"106","author":"E. Kovari","year":"2003","unstructured":"Kovari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, Giannakopoulos P (2003) Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson\u2019s disease. Acta Neuropathol (Berl) 106: 83\u201388","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR97","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00005072-199812000-00001","volume":"57","author":"P.L. Lantos","year":"1998","unstructured":"Lantos PL (1998) The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 57: 1099\u20131111","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"P.H. Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HI, Bang OY, Joo IS, Huh K (2006) The plasma alphasynuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Transm 113: 1435\u20131439","journal-title":"J Neural Transm"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1385\/1-59259-326-7:259","volume-title":"Mental and behavioral dysfunction in movement disorders","author":"G. Levy","year":"2003","unstructured":"Levy G, Marder K (2003) Prevalence, incidence, and risk factors for dementia in Parkinson\u2019s disease. In: B\u00e9dard M-A (ed) Mental and behavioral dysfunction in movement disorders. Humana Press, Totowa, NJ, pp 259\u2013270"},{"key":"12_CR100","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J. Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293: 1487\u20131491","journal-title":"Science"},{"key":"12_CR101","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.46.4.922","volume":"46","author":"I. Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D\u2019Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 46: 922\u2013930","journal-title":"Neurology"},{"key":"12_CR102","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.55.7.969","volume":"55","author":"I. Litvan","year":"1998","unstructured":"Litvan I, Maclntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D\u2019Olhaberriague L, Pearce RK, Agid Y (1998) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55: 969\u2013978","journal-title":"Arch Neurol"},{"key":"12_CR103","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I. Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK (2003) Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18: 467\u2013486","journal-title":"Mov Disord"},{"key":"12_CR104","volume-title":"Atypical parkinsonian disorders \u2014 clinical and research aspects","year":"2005","unstructured":"Litvan I (ed) (2005) Atypical parkinsonian disorders \u2014 clinical and research aspects. Humana Press, Totowa, NJ"},{"key":"12_CR105","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1750-3639.1998.tb00163.x","volume":"8","author":"J. Lowe","year":"1998","unstructured":"Lowe J (1998) Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 8: 403\u2013406","journal-title":"Brain Pathol"},{"key":"12_CR106","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","volume":"31","author":"P.K. Mandai","year":"2006","unstructured":"Mandai PK, Pettegrew JW, Masliah E, Hamilton RL, Mandai R (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease. Neurochem Res 31: 1153\u20131162","journal-title":"Neurochem Res"},{"key":"12_CR107","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn1199","volume":"4","author":"E. Maries","year":"2003","unstructured":"Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of alpha-synuclein in Parkinson\u2019s disease: insights from animal models. Nat Rev Neurosci 4: 727\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"12_CR108","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-0404.2005.00553.x","volume":"113","author":"G.A. Marshall","year":"2006","unstructured":"Marshall GA, Shchelchkov E, Kaufer DI, Ivanco LS, Bohnen NI (2006) White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia. Acta Neurol Scand 113: 87\u201391","journal-title":"Acta Neurol Scand"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-510X(99)00327-5","volume":"174","author":"W. Marui","year":"2000","unstructured":"Marui W, Iseki E, Ueda K, Kosaka K (2000) Occurrence of human alphasynuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer\u2019s disease. J Neurol Sci 174: 81\u201384","journal-title":"J Neurol Sci"},{"key":"12_CR110","doi-asserted-by":"publisher","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E. Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA 98: 12245\u201312250","journal-title":"Proc Natl Acad Sci USA"},{"key":"12_CR111","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"P.M. Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alphasynuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol (Berl) 100: 285\u2013290","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR112","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"I.G. McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113\u20131124","journal-title":"Neurology"},{"key":"12_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I.G. McKeith","year":"2004","unstructured":"McKeith IG, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O\u2019Brien J, Playfer J, Reid W (2004) Dementia with Lewy bodies. Lancet Neurol 3: 19\u201328","journal-title":"Lancet Neurol"},{"key":"12_CR114","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jnnp.70.6.739","volume":"70","author":"R.H. McShane","year":"2001","unstructured":"McShane RH, Nagy Z, Esiri MM, King E, Joachim C, Sullivan N, Smith AD (2001) Anosmia in dementia is associated with Lewy bodies rather than Alzheimerc pathology. J Neurol Neurosurg Psychiatry 70: 739\u2013743","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/ageing\/28.2.99","volume":"28","author":"J. Meara","year":"1999","unstructured":"Meara J, Bhowmick BK, Hobson P (1999) Accuracy of diagnosis in patients with presumed Parkinson\u2019s disease. Age Ageing 28: 99\u2013102","journal-title":"Age Ageing"},{"key":"12_CR116","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneur.55.1.84","volume":"55","author":"R.I. Mesholam","year":"1998","unstructured":"Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimervc and Parkinson\u2019s diseases. Arch Neurol 55: 84\u201390","journal-title":"Arch Neurol"},{"key":"12_CR117","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/brain\/awh198","volume":"127","author":"A.W. Michell","year":"2004","unstructured":"Michell AW, Lewis SJ, Foltynie T, Barker RA (2004) Biomarkers and Parkinson\u2019s disease. Brain 127: 1693\u20131705","journal-title":"Brain"},{"key":"12_CR118","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jnen\/64.2.156","volume":"64","author":"I. Mikolaenko","year":"2005","unstructured":"Mikolaenko I, Pletnikova O, Kawas CH, O\u2019Brien R, Resnick SM, Crain B, Troncoso JC (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the baltimore longitudinal study of aging (BLSA). J Neuropathol Exp Neurol 64: 156\u2013162","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.20941","volume":"60","author":"A. Minguez-Castellanos","year":"2006","unstructured":"Minguez-Castellanos A, Escamilla-Sevilla F, Chamorro CE, Arnaiz C, Rodriguez-Fernandez A, Rebollo AC, Gomez-Rio M, Ortega-Moreno A, Concha A, Munoz DG (2006) Do alpha-synuclein aggregates (ASA) in peripheral autonomie neurons precede development of diseases with Lewy bodies (DLB)? a cohort study. Ann Neurol 60, S10: S78\u2013S79","journal-title":"Ann Neurol"},{"key":"12_CR120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"S.S. Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for alzheimer\u2019s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41: 479\u2013486","journal-title":"Neurology"},{"key":"12_CR121","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","volume":"15","author":"I. Mizuta","year":"2006","unstructured":"Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, Nagai Y, Oka A, Inoko H, Fukae J, Saito Y, Sawabe M, Murayama S, Yamamoto M, Hattori N, Murata M, Toda T (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson\u2019s disease. Hum Mol Genet 15: 1151\u20131158","journal-title":"Hum Mol Genet"},{"key":"12_CR122","unstructured":"Mollenhauer B, Cullen V, Krastins B, llana Kahn I, Locascio JJ, Trenkwalder C, Schulz-Schaeffer W, Kretzschmar HA, Sarracino D, VonSattel J-P, el-Agnaf OMA, Schlossmacher MG (2007) Methods to directly quantify alpha-synuclein in neural cell medium and in cerebrospinal fluid from patients with parkinsonism and dementia. Nat Med submitted"},{"key":"12_CR123","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.jnen.0000171652.40083.15","volume":"64","author":"C.M. Muller","year":"2005","unstructured":"Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter-and intra-rater reliability. J Neuropathol Exp Neurol 64: 623\u2013628","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 5","key":"12_CR124","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1002\/ana.10571","volume":"54","author":"D.G. Munoz","year":"2003","unstructured":"Munoz DG, Dickson DW, Bergeron C, Mackenzie IR, Delacourte A, Zhukareva V (2003) The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 54Suppl 5: S24\u2013S28","journal-title":"Ann Neurol"},{"key":"12_CR125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A. Nagano-Saito","year":"2005","unstructured":"Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64: 224\u2013229","journal-title":"Neurology"},{"key":"12_CR126","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-004-0834-2","volume":"107","author":"M. Neumann","year":"2004","unstructured":"Neumann M, Muller V, Gorner K, Kretzschmar HA, Haass C, Kahle PJ (2004) Pathological properties of the Parkinson\u2019s disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick\u2019s disease. Acta Neuropathol (Berl) 107: 489\u2013496","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR127","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/jnnp.2003.032003","volume":"76","author":"J.M. Olichney","year":"2005","unstructured":"Olichney JM, Murphy C, Hofstetter CR, Foster K, Hansen LA, Thal LJ, Katzman R (2005) Anosmia is very common in the Lewy body variant of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 76: 1342\u20131347","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR128","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mds.10680","volume":"19","author":"Y. Osaki","year":"2004","unstructured":"Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, Quinn N (2004) Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 19: 181\u2013189","journal-title":"Mov Disord"},{"key":"12_CR129","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0404.2005.00411.x","volume":"111","author":"S. Papapetropoulos","year":"2005","unstructured":"Papapetropoulos S, Lieberman A, Gonzalez J, Mash DC (2005) Can Alzheimer\u2019s type pathology influence the clinical phenotype of Parkinson\u2019s disease? Acta Neurol Scand 111: 353\u2013359","journal-title":"Acta Neurol Scand"},{"key":"12_CR130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","volume":"62","author":"L. Parkkinen","year":"2003","unstructured":"Parkkinen L, Soininen H, Alafuzoff I (2003) Regional distribution of alphasynuclein pathology in unimpaired aging and Alzheimer disease. J Neuropathol Exp Neurol 62: 363\u2013367","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 3","key":"12_CR131","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/S0924-977X(04)80006-3","volume":"14","author":"E.K. Perry","year":"2004","unstructured":"Perry EK (2004) Lewy body disease: How are dementia with Lewy bodies and Parkinson\u2019s disease dementia related? Eur Neuropsychopharm 14Suppl 3: S113\u2013S114","journal-title":"Eur Neuropsychopharm"},{"key":"12_CR132","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O. Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC (2005) Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 26: 1183\u20131192","journal-title":"Neurobiol Aging"},{"key":"12_CR133","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/archneur.61.12.1915","volume":"61","author":"A. Popescu","year":"2004","unstructured":"Popescu A, Lippa CF, Lee VM, Trojanowski JQ (2004) Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol 61: 1915\u20131919","journal-title":"Arch Neurol"},{"key":"12_CR134","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/mds.21054","volume":"21","author":"J. Prestel","year":"2006","unstructured":"Prestel J, Schweitzer KJ, Hofer A, Gasser T, Berg D (2006) Predictive value of transcranial sonography in the diagnosis of Parkinson\u2019s disease. Mov Disord 21: 1763\u20131765","journal-title":"Mov Disord"},{"key":"12_CR135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1017\/S0317167100031814","volume":"18","author":"A.H. Rajput","year":"1991","unstructured":"Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in parkinsonism \u2014 a prospective study. Can J Neurol Sci 18: 275\u2013278","journal-title":"Can J Neurol Sci"},{"key":"12_CR136","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","volume":"64","author":"B. Ravina","year":"2005","unstructured":"Ravina B, Eideiberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langsten JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R (2005) The role of radiotracer imaging in Parkinson disease. Neurology 64: 208\u2013215","journal-title":"Neurology"},{"key":"12_CR137","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y. Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62: 644\u2013654","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR138","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnen\/63.7.742","volume":"63","author":"Y. R. N. Saito","year":"2004","unstructured":"Saito Y Ruberu NN, Sawabe M, Arai T, Kazama H, Hosoi T, Yamanouchi H, Murayama S (2004) Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 63: 742\u2013749","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR139","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","volume":"17","author":"M. Sasaki","year":"2006","unstructured":"Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson\u2019s disease. Neuroreport 17: 1215\u20131218","journal-title":"Neuroreport"},{"key":"12_CR140","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s004010050454","volume":"91","author":"M.L. Schmidt","year":"1996","unstructured":"Schmidt ML, Martin 1A, Lee VM, Trojanowski JQ (1996) Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer\u2019s disease and Lewy body disorders. Acta Neuropathol (Berl) 91: 475\u2013481","journal-title":"Acta Neuropathol (Berl)"},{"key":"12_CR141","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/jnnp.73.5.529","volume":"73","author":"A. Schrag","year":"2002","unstructured":"Schrag A, Ben-Shlomo Y, Quinn N (2002) How valid is the clinical diagnosis of Parkinson\u2019s disease in the community? J Neurol Neurosurg Psychiatry 73: 529\u2013534","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 15","key":"12_CR142","first-page":"S","volume":"21","author":"R. Sengoku","year":"2006","unstructured":"Sengoku R, Saito Y, Ikemura M, Kanemaru K, Sawabe M, Inoue K, Murayama S (2006) Pathological background of clinical Parkinsonc disease in the 1970\u2019s (Abstr). Mov Disord 21Suppl 15: S\u2013607","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"12_CR143","first-page":"A3 91","volume":"45","author":"K. Seppi","year":"2000","unstructured":"Seppi K, Wenning GK, Jellinger K et al. (2000) Disease progression of dementia with Lewy bodies: a clinico-pathological study (abstract). Neurology 45Suppl 3: A3 91","journal-title":"Neurology"},{"key":"12_CR144","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.jnen.0000218441.00040.82","volume":"65","author":"C.Y. Shao","year":"2006","unstructured":"Shao CY, Crary JF, Rao C, Sacktor TC, Mirra SS (2006) Atypical protein kinase C in neurodegenerative disease II: PKCiota\/lambda in tauopathies and alpha-synucleinopathies. J Neuropathol Exp Neurol 65: 327\u2013335","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 3","key":"12_CR145","doi-asserted-by":"publisher","first-page":"iii30","DOI":"10.1007\/s00415-006-3006-6","volume":"253","author":"H. Shinotoh","year":"2006","unstructured":"Shinotoh H (2006) Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies. J Neurol 253Suppl 3: iii30\u2013iii34","journal-title":"J Neurol"},{"key":"12_CR146","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neulet.2006.07.006","volume":"405","author":"C.W. Shults","year":"2006","unstructured":"Shults CW, Barrett JM, Fontaine D (2006) Alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson\u2019s disease and multiple system atrophy. Neurosci Lett 405: 223\u2013225","journal-title":"Neurosci Lett"},{"key":"12_CR147","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00019052-200402000-00009","volume":"17","author":"I. Sibon","year":"2004","unstructured":"Sibon I, Tison F (2004) Vascular parkinsonism. Curr Opin Neurol 17: 49\u201354","journal-title":"Curr Opin Neurol"},{"key":"12_CR148","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"M.G. Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839\u2013840","journal-title":"Nature"},{"key":"12_CR149","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1212\/01.wnl.0000215437.80053.d0","volume":"66","author":"O. Suchowersky","year":"2006","unstructured":"Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ (2006) Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology. Neurology 66: 968\u2013975","journal-title":"Neurology"},{"key":"12_CR150","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/archneur.62.2.281","volume":"62","author":"C. Summerfield","year":"2005","unstructured":"Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, Pastor P, Ramirez-Ruiz B, Mercader J (2005) Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 62: 281\u2013285","journal-title":"Arch Neurol"},{"key":"12_CR151","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/archneur.63.6.826","volume":"63","author":"M. Sun","year":"2006","unstructured":"Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF (2006) Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol 63: 826\u2013832","journal-title":"Arch Neurol"},{"key":"12_CR152","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/01.WNL.0000153070.82309.D4","volume":"64","author":"C.W. Tam","year":"2005","unstructured":"Tam CW, Burton EJ, McKeith IG, Burn DJ, O\u2019Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64: 861\u2013865","journal-title":"Neurology"},{"key":"12_CR153","first-page":"1775","volume":"46","author":"D.N. Tipre","year":"2005","unstructured":"Tipre DN, Goldstein DS (2005) Cardiac and extracardiac sympathetic denervation in Parkinson\u2019s disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med 46: 1775\u20131781","journal-title":"J Nucl Med"},{"key":"12_CR154","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","volume":"59","author":"P. Tiraboschi","year":"2002","unstructured":"Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J (2002) Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry 59: 946\u2013951","journal-title":"Arch Gen Psychiatry"},{"key":"12_CR155","first-page":"121","volume-title":"Scientific basis for the treatment of Parkinson\u2019s disease","author":"M. Toft","year":"2005","unstructured":"Toft M, Fairer M (2005) Genetics of Parkinson\u2019s disease. In: G\u00e1lvez-Jimenez N (ed) Scientific basis for the treatment of Parkinson\u2019s disease, 2nd edn. Taylor & Francis, New York, pp 121\u2013129","edition":"2nd edn."},{"key":"12_CR156","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T. Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, Locascio JJ, Schlossmacher MG, El-Agnaf OM (2006) Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun 349: 162\u2013166","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR157","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E. Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson\u2019s disease. Lancet Neurol 5: 75\u201386","journal-title":"Lancet Neurol"},{"key":"12_CR158","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00401-003-0670-9","volume":"105","author":"Y. Trembath","year":"2003","unstructured":"Trembath Y, Rosenberg C, Ervin JF, Schmechel DE, Gaskell P, Pericak-Vance MVJ, Hulette CM (2003) Lewy body pathology is a frequent copathology in familial Alzheimer\u2019s disease. Acta Neuropathol 105: 484\u2013488","journal-title":"Acta Neuropathol"},{"key":"12_CR159","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnen\/60.12.1123","volume":"60","author":"J.Q. Trojanowski","year":"2001","unstructured":"Trojanowski JQ, Dickson D (2001) Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol 60: 1123\u20131126","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR160","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.jnen.0000218449.17073.43","volume":"65","author":"H. Uchikado","year":"2006","unstructured":"Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006a) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65: 387\u2013395","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR161","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","volume":"65","author":"H. Uchikado","year":"2006","unstructured":"Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006b) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65: 685\u2013697","journal-title":"J Neuropathol Exp Neurol"},{"key":"12_CR162","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K. Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249: 180\u2013182","journal-title":"Neurosci Lett"},{"key":"12_CR163","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2006.05.011","volume":"345","author":"M. Waragai","year":"2006","unstructured":"Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, Masliah E, Akatsu H, Yamada T, Hashimoto M (2006) Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson\u2019s disease. Biochem Biophys Res Commun 345: 967\u2013972","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR164","volume-title":"Advances in neurology: Parkinson\u2019s disease: anatomy, pathology, and therapy","author":"C. Ward","year":"1990","unstructured":"Ward C, Gibb W (1990) Research diagnostic criteria for Parkinson\u2019s disease. In: Streifler M, Korczyn AD, Melamed E, Youdim M (eds) Advances in neurology: Parkinson\u2019s disease: anatomy, pathology, and therapy. Raven Press, New York"},{"key":"12_CR165","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","volume":"68","author":"G.K. Wenning","year":"2000","unstructured":"Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson\u2019s disease? J Neurol Neurosurg Psychiatry 68: 434\u2013440","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12_CR166","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mds.20550","volume":"20","author":"L. Zecca","year":"2005","unstructured":"Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, Tampellini D, Riederer P, Gerlach M, Becker G (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20: 1278\u20131285","journal-title":"Mov Disord"},{"key":"12_CR167","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00702-004-0178-z","volume":"111","author":"D.J. Zgaljardic","year":"2004","unstructured":"Zgaljardic DJ, Foldi NS, Borod JC (2004) Cognitive and behavioral dysfunction in Parkinson\u2019s disease: neurochemical and clinicopathological contributions. J Neural Transm 111: 1287\u20131303","journal-title":"J Neural Transm"},{"key":"12_CR168","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neurobiolaging.2005.02.004","volume":"27","author":"I. Ziabreva","year":"2006","unstructured":"Ziabreva I, Ballard CG, Aarsland D, Larsen JP, McKeith IG, Perry RH, Perry EK (2006) Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism. Neurobiol Aging 27: 433\u2013438","journal-title":"Neurobiol Aging"},{"key":"12_CR169","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A. Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Fairer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601\u2013607","journal-title":"Neuron"}],"container-title":["Journal of Neural Transmission. Supplementa","Neuropsychiatric Disorders An Integrative Approach"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-73574-9_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:30:04Z","timestamp":1684157404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-73574-9_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783211735732","9783211735749"],"references-count":169,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-73574-9_12","relation":{},"subject":[]}}